News

New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

Regulatory News:

Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE:

BusinessWire_EN

0

Poxel Announces Multiple TWYMEEG® (Imeglimin) Abstracts Accepted for Oral Presentation

Regulatory News:

POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic

BusinessWire_EN

0

FOX Sports Mexico Signs Multi-year Agreement on EUTELSAT 117° West A to Distribute Content Across Mexico

Regulatory News:

Eutelsat Communications (Euronext Paris: ETL) announces that it has signed a multi-year agreement with FOX Sports Mexico, a leading sports broadcaster, to distribute channels

BusinessWire_EN

0

Verimatrix XTD gewinnt 2023 Global Infosec Award

Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Verimatrix XTD (Extended

BusinessWire_DE

0

Industry Executives Across Latin America Explore Insights and Strategies for Success at Dassault Systèmes’ Inaugural “Leadership Meeting”

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its inaugural “Leadership Meeting” May 2-5, 2023, taking place at the Copacabana Palace Hotel in Rio de Janeiro. The four

BusinessWire_EN

0

Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023

Regulatory News:

Median Technologies (ALMDT:PA) announced today that the two webcasts during which Fredrik Brag, CEO and Founder will provide a corporate update, are rescheduled from May 3^rd to

BusinessWire_EN

0

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023

Regulatory News:

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that the Company’s

BusinessWire_EN

0

Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023

Regulatory News:

Median Technologies (Euronext Growth - ALMDT) (Paris;ALMDT) whose Board of Directors met on April 19, 2023 to approve the consolidated financial statements for the financial

BusinessWire_EN

0

Verimatrix mit dem 2023 NAB Show „Produkt des Jahres"-Award ausgezeichnet

Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Verimatrix Streamkeeper mit

BusinessWire_DE

0

Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference

Regulatory News:

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, is pleased to announce its participation

BusinessWire_EN

0

Televisa Selects Eutelsat to Further Expand Video Coverage Over Europe

Regulatory News:

Grupo Televisa, a leading producer of Spanish-speaking content, has selected Eutelsat Communications (Euronext Paris: ETL) to further expand the reach of its video services in

BusinessWire_EN

0